month I discussed vitamin B12's
importance in the practice of neural therapy and some of the practical
aspects of its use. What the discussion boiled down to was a recommendation
that daily vitamin B12 injections should be given as a therapeutic trial
whenever deficiency is suspected.
of my readers, Dr Mason-Woods ND asked why I recommended cyanocobalamin, when methycobalamin is a more effective and more
physiological substance. He points
out the advantages of the methyl form:
� no toxicity from the cyanide residue
� better absorption and retention in the tissues
� better for vision (the cyano form is ineffective in this application)
� helps in sleep regulation.
answer Dr Mason-Woods' question: in an
ideal world, methylcobalamin would be my
first choice also. However (at least
where I practice in Ontario,
methylcobalamin is less available, is more expensive and is not covered by the
seniors' drug plans. Cyanocobalamin has (in this jurisdiction and in the last
year) become a non-prescription item, is inexpensive and can be purchased in 30
ml bottles in some supermarkets. For these reasons, I save methylcobalamin for
situation is similar to that of folic acid and folate. Folic
acid, like cyanocobalamin, is a pharmaceutically engineered product. It is
cheap and easily available, but folate is what is found in nature, is more
effective and probably safer.
leaving the subjects of cobalamin and folate, I would like to share a "pearl",
taught me by another colleague, Barb Powell MD. This has to do with unusual
requirements of vitamin B12 and folate in some of our patients.
month I mentioned that after one week of vitamin B12 injections, the patient
should either feel better, or not. If
there is no improvement, B12 deficiency is unlikely to be the problem. However
if the patient feels better, the next question is going to be: when should the
injections be repeated?
answer seems to be: whenever needed. Some patients will need a repeat injection in a few weeks; some will
need repeat injections every two days. If the patient needs frequent injections there is likely an
abnormal genetic defect in the body's handling of both cobalamin and folate - a
(MTHFR) pleomorphism. This is surprisingly common in patients with fatigue,
depression, detoxification difficulties, and signs of B12 and/or folate
deficiency. A history of thromboembolism
or children with neural tube defect or congenital heart problems are additional
clues. And a high serum homocysteine can
be another marker.
for MTHFR pleomorphism is commercially available, and in Ontario, Canada,
is even covered by the government health insurance plan. It is tucked away in a panel of genetic tests
used in investigating thromboembolic disease. The thrombophilia panel includes
two genetic variants: p.ALA222Val and p.Glu429Ala. If one or both are present, the degree
dependency" (Dr Powell's term) can be estimated by whether one or both are
present and whether the genes are heterozygous or homozygous.
the patient is homozygous for one or both genes, he/she may require daily supplementation of dietary folate of 5 mgm/day or
more, in addition to frequent doses of vitamin B12. The response to treatment may be slow. The
full benefit of high dose folate may take six months or more to be evident.
Both Dr. Powell and I have seen patients' general health and whole world view
change with this simple treatment.
therapy's most distinctive attribute is the detection and treatment of
interference fields. However, the
skilled neural therapist knows that simply treating interference fields can
take one only so far. The health of the
whole nervous system must be taken into account. Ensuring
that the patient has adequate vitamin B12 and folate are key factors in
optimizing the patient's health and his/her response to neural therapy.
Next introductory neural therapy course on November 12th
and 13th, 2010 in Ottawa,
Three-day introductory neural therapy course in Sydney,
Australia March 9-11, 2011. For more information contact George Stylian DO: 02
9524 4620, 0425 237 995 or firstname.lastname@example.org;
FAX: 02 9525 9998